The document says a skin condition called alopeciaareata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.
A 35-year-old with alopeciaareata has tried finasteride, topical and oral minoxidil, and dutasteride without success in stopping hair loss. The dermatologist suggests JAK inhibitors, but they are too costly, leading to uncertainty about the cause of hair loss.
How diffuse unpatterned alopecia (DUPA) is not an invitation to self-diagnose oneself with aggressive AGA and that seeking a specialized dermatologist may help people experiencing hair loss. Treatment options discussed include topical clobetasol propionate, oral minoxidil, and discontinuing finasteride.
The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopeciaareata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopeciaareata, and the lack of results from using finasteride, dutasteride, and minoxidil.
A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.